AMCP’s guidance translates CMS’s expectations for patient centered, evidence informed formulary decisions into practical steps payers can act on today without adding unnecessary burden to P&T workflows.
Marketing Insights Best Practices | Cancer | Panel of Experts Discuss The Role of BTKi's in the Management of Chronic Lymphocytic Leukemia (CLL) | Jan 27, 2023
For more disease state research, view the Market Insights Program.
AMCP offers a wide variety of educational opportunities, from events and webinars to online training.